Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.
NeurologyLive® Friday 5 — May 17, 2024
Episode 115: Expanding Access to Ublituximab and AntiCD20s for Multiple Sclerosis
Cross-Compatibility Issues With Autoinjectors Highlighted in New FDA Labeling Update of Glatiramer Acetate Injection
Special Episode: FDA Approves Diazepam Buccal Film for Pediatric Seizures
Building the Archetype for MOGAD Care: Introducing Mayo’s New Clinic
Neuro News Roundup: Huntington Disease Awareness Day – Latest Literature